Capital Change Notice - Employee Share Scheme (F25 Q4)
Capital Change Notice
Section 1: Issuer information
Name of issuer PaySauce Limited
NZX ticker code PYS
Class of financial product Ordinary Shares
ISIN (If unknown, check on NZX website) N/A
Currency NZD
Section 2: Capital change details
Number issued 524,267
Nominal value (if any) N/A
Issue/acquisition/redemption price per security
$0.1710 per share (being the
Average Market Price of a
PYS share at the date of
allotment
Nature of the payment (for example, cash or other
consideration)
1. For 465,787 shares, cash.
2. For 58,480 shares, N/A.
Amount paid up (if not in full) Fully Paid
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the number of
Financial Products of the Class, excluding any Treasury Stock,
in existence)
0.37% of all ordinary shares
on issue in PYS
For an issue of Convertible Financial Products or Options, the
principal terms of Conversion (for example the Conversion
price and Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial Product) or
the Option (for example, the exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and specific authority
for issue/acquisition/redemption/ (the reason for change must
be identified here)
1. 465,787 shares are issued
to employees as part of the
FY25 Employee Share
Scheme, being issued to
staff for performance in Q4
of FY25.
2. 58,480 shares are issued to
Mark Samlal in lieu of
Directors Fees for the
quarter ended 31 March
2025.
Total number of Financial Products of the Class after the
issue/acquisition/redemption/Conversion (excluding Treasury
Stock) and the total number of Financial Products of the Class
held as Treasury Stock after the issue/acquisition/redemption.
143,693,093
In the case of an acquisition of shares, whether those shares
are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or redemption,
including a reference to the rule pursuant to which the issue,
acquisition, or redemption is made
Listing Rules 4.6 and 4.7 and
Board Resolution.
Terms or details of the issue, acquisition, or redemption (for
example: restrictions, escrow arrangements)
The new shares will rank
equally with all other fully paid
ordinary shares on issue.
Date of issue/acquisition/redemption 21 April 2025
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement Jaime Monaghan
Contact person for this announcement Jaime Monaghan
Contact phone number +64 22 5246 366
Contact email address jaime@paysauce.com
Date of release through MAP
21 April 2025
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notices - NZ & AU ESPS2025-04-07
“Capital Change Notice 7 April 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - North America ESPP2025-04-02
“Capital Change Notice 3 April 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Capital Change Notice - North America ESPP2025-07-02
“Capital Change Notice 2 July 2025 Issue of ordinary shares This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) in connection with one or more of FPH’s…”